DIANE NARAINE: Open Payments
NPI 1972080612 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,096 in 146 payments from 22 companies in 2025. Trend: 2023 $2,646 · 2024 $3,558 · 2025 $3,096
Food & beverage: $2,262Honoraria: $750Education: $84
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 11 | $958 |
| ABBVIE INC. | 41 | $506 |
| Janssen Biotech, Inc. | 22 | $309 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $216 |
| Ipsen Biopharmaceuticals, Inc | 7 | $189 |
| Madrigal Pharmaceuticals | 4 | $149 |
| Aimmune Therapeutics, Inc. | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Lilly USA, LLC | 5 | $87 |
| VIVUS LLC | 4 | $70 |
Products named: Sucraid, TREMFYA, RINVOQ, XIFAXAN, IQIRVO, REZDIFFRA, ZENPEP, CREON.
Industry payments across NJ — which companies pay providers there.
